Altria, the parent company of Marlboro cigarettes, has filed a lawsuit against the Food and Drug Administration (FDA). The suit challenges the FDA’s tobacco product review system, alleging it is unconstitutionally slow and burdensome. Altria claims the agency’s lengthy review process has prevented them from introducing new, potentially less harmful tobacco and nicotine products to the market. The lawsuit specifically focuses on the FDA’s Marketing Granted Orders (MGOs), a key component of the agency’s authority to regulate tobacco products. Altria argues the FDA is effectively denying their applications without providing sufficient explanation. This legal action escalates the ongoing tension between the tobacco industry and the FDA over efforts to reduce smoking rates. The outcome of the case could significantly impact the future of tobacco and nicotine product regulation in the United States.